+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Visceral Pain Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • ID: 5327647
  • Report
  • August 2020
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
Visceral pain is defined as the pain that results from the nociceptors activation of the pelvic, thoracic or abdominal bowels (organs). The visceral structures are highly sensitive to stretch (distension), inflammation, and ischemia, but moderately insensitive to other stimuli that usually evoke pain such as burning or cutting. The symptoms of visceral pain are vomiting, nausea, changes in vital signs, and emotional manifestations. Pregabalin or gabapentin are some of the medications used for visceral pain treatment.

Market Dynamics

The ongoing research and development by pharmaceutical companies and increasing investments by many governments are expected to propel the visceral pain treatment market growth over the forecast period. For instance, in February 2020, DNDi (Drugs for Neglected Types initiative) and Novartis entered into a joint license agreement to co-develop a potential new treatment for visceral leishmaniasis. Furthermore, the rising prevalence of irritable bowel syndrome (IBS) across the globe is likely to drive the market growth. For instance, in 2016, according to the IFFGD (International Foundation for Gastrointestinal Disorders), around 10 to 15 per cent of the adult population across the globe are affected by IBS each year.

Moreover, key players in this market are highly investing in research and development to develop, create, and commercialize novel drugs for visceral pain, which will create growth opportunities in the global visceral pain treatment market over the forecast period. However, the lack of specific treatment for visceral pain such as Crohn’s disease and irritable bowel syndrome is expected to restrict the market growth in the near future.

Key features of the study:
  • This report provides in-depth analysis of the global visceral pain treatment market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global visceral pain treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
  • Key players covered as a part of this study are Addex Therapeutics Ltd., AstraZeneca, Astellas Pharma Inc., Allergan, Chromocell Corporation, Takeda, GIcare Pharma Inc., Abbvie, Grunenthal GmbH, Johnson & Johnson, Neurim Pharmaceuticals Ltd, and Medestea Research & Production S.p.A.
  • Insights from this report would allow marketers and management authorities of companies to make an informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global visceral pain treatment market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for visceral pain treatment market, research and consulting firms, new entrants, and financial analysts.
Detailed Segmentation:

Global Visceral Pain Treatment Market, By Drug Type:
  • Pain modifiers
  • Tricyclic Anticonvulsant
  • Tricyclic Antidepressants
  • Analgesics
  • Narcotics
  • NSAID
  • Others
Global Visceral Pain Treatment Market, By Indication:
  • Irritable bowel syndrome
  • Chronic prostatitis
  • Interstitial cystitis
  • Crohn’s Disease
Global Visceral Pain Treatment Market, By Distribution Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Channels
Global Visceral Pain Treatment Market, By Region:
  • North America
 By Country:
  • U.S.
  • Canada
  • Europe
 By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
 By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Latin America
 By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
 By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
 By Country/Region:
  • South Africa
  • North Africa
  • Central Africa
Note: Product cover images may vary from those shown
1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Overview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Indication
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Opportunity Map
3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Advancements in Visceral Pain Treatment
  • Key Developments
  • Acquisition, Collaborations & Partnerships
  • Epidemiology
4. Global Visceral Pain Treatment Market, Impact of Coronavirus (Covid-19) Pandemic
  • Pre-COVID situation
  • Post-COVID demand
  • Need for Visceral Pain Treatment
5. Global Visceral Pain Treatment Market, By Drug Type, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Pain modifiers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Pain Modifiers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Tricyclic Anticonvulsant
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Tricyclic Antidepressants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Analgesics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Narcotics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • NSAID
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
6. Global Visceral Pain Treatment Market, By Indication, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Irritable bowel syndrome
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Chronic prostatitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Interstitial cystitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Crohn's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
7. Global Visceral Pain Treatment Market, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Hospital Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Retail Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Online Channels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
8. Global Visceral Pain Treatment Market, By Region, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, By Region, 2020 and 2027(%)
  • Y-o-Y Growth Analysis, By Region, 2017 -2027
  • Regional Trends
  • North America
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • U.S.
  • Canada
  • Europe
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Africa
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa
  • Middle East
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
9. Competitive Landscape
  • Company Profiles
  • Addex Therapeutics Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • AstraZeneca
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Astellas Pharma Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Allergan
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Chromocell Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Takeda
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • GIcare Pharma Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Abbvie
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Grunenthal GmbH
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Johnson & Johnson
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Neurim Pharmaceuticals Ltd
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Medestea Research & Production S.p.A.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
10. Section
  • References
  • Research Methodology
  • About us and Sales Contact
Note: Product cover images may vary from those shown
  • Addex Therapeutics Ltd., AstraZeneca, Astellas Pharma Inc., Allergan, Chromocell Corporation, Takeda, GIcare Pharma Inc., Abbvie, Grunenthal GmbH, Johnson & Johnson, Neurim Pharmaceuticals Ltd, and Medestea Research & Production S.p.A.
Note: Product cover images may vary from those shown
Adroll
adroll